Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 2/2020

01-04-2020 | Lymphoma | Short Communication

Nasal-Type Extranodal Natural Killer/T Cell Lymphoma with Meningeal Involvement: A Case Report and Literature Review

Authors: Chunli Yang, Hongyu Zhuo, Liqun Zou

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 2/2020

Login to get access

Abstract

Objectives

We report a case of a 26-year-old man diagnosed with nasal-type extranodal natural killer/T cell lymphoma (ENKTL) extending beyond the nasal cavity. Complete response was achieved after therapy, followed by rapid metastasis to the meningeal nerve fibres. The overall survival (OS) of the patient was 15 months. To better understand ENKTL with meningeal involvement, we summarized the clinical features of the 10 cases involving meningeal metastasis in ENKTL reported in the English literature.

Methods

The patient was admitted for the ENKTL diagnosis, and positron emission tomography-computed tomography showed the disease stage and response. When central nervous system (CNS) infiltration was suspected, magnetic resonance imaging (MRI) of the brain and spinal cord was performed, as well as cerebrospinal fluid (CSF) analysis with flow cytometric immunophenotyping.

Results

MRI of the brain and spinal cord revealed normal results. CSF analysis with flow cytometric immunophenotyping showed NK/T lymphoma cell infiltration.

Conclusion

Meningeal metastasis of ENKTL is rare; when patients present with nervous system symptoms, CNS metastasis should be considered as a possibility, even in the early stage. The OS of our patient was 15 months, which is the longest survival time reported in the literature, probably due to early diagnosis and comprehensive management, including intrathecal therapy, chemotherapy and radiotherapy of the whole brain and spinal cord.
Literature
1.
go back to reference Luther N, Greenfield JP, Chadburn A, Schwartz TH (2005) Intracranial nasal natural killer/T-cell lymphoma: immunopathologically-confirmed case and review of literature. J Neurooncol 75:185–188CrossRef Luther N, Greenfield JP, Chadburn A, Schwartz TH (2005) Intracranial nasal natural killer/T-cell lymphoma: immunopathologically-confirmed case and review of literature. J Neurooncol 75:185–188CrossRef
2.
go back to reference Van Gorp J, De Bruin PC, Sie-Go DM et al (1995) Nasal T-cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 cases. Histopathology 27:139–148CrossRef Van Gorp J, De Bruin PC, Sie-Go DM et al (1995) Nasal T-cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 cases. Histopathology 27:139–148CrossRef
3.
go back to reference Kim YB, Chang SK, Yang W et al (2003) Primary NK/T cell lymphoma of the testis. Acta Haematol 109:95–100CrossRef Kim YB, Chang SK, Yang W et al (2003) Primary NK/T cell lymphoma of the testis. Acta Haematol 109:95–100CrossRef
4.
go back to reference Papalkar D, Sharma S, Francis IC et al (2009) A rapidly fatal case of T-cell lymphoma presenting as idiopathic orbital inflammation. Orbit 24:131–133CrossRef Papalkar D, Sharma S, Francis IC et al (2009) A rapidly fatal case of T-cell lymphoma presenting as idiopathic orbital inflammation. Orbit 24:131–133CrossRef
5.
go back to reference Dunning KK, Wudhikarn K, Safo A et al (2009) Adrenal extranodal NK/T-cell lymphoma diagnosed by fine-needle aspiration and cerebrospinal fluid cytology and immunophenotyping: a case report. Diagn Cytopathol 37:686–695CrossRef Dunning KK, Wudhikarn K, Safo A et al (2009) Adrenal extranodal NK/T-cell lymphoma diagnosed by fine-needle aspiration and cerebrospinal fluid cytology and immunophenotyping: a case report. Diagn Cytopathol 37:686–695CrossRef
6.
go back to reference Erős N, Marschalkó M, Balassa K et al (2010) Central nervous system involvement in CD4 +/CD56 + hematodermic neoplasm: a report of two cases. J Neurooncol 97:301–304CrossRef Erős N, Marschalkó M, Balassa K et al (2010) Central nervous system involvement in CD4 +/CD56 + hematodermic neoplasm: a report of two cases. J Neurooncol 97:301–304CrossRef
7.
go back to reference Hildyard C, Sheikh S, Eyre T, Collins G (2013) Extranodal NK/T cell lymphoma, nasal type, presenting with meningeal infiltration in a Caucasian female. Br J Haematol 163:550CrossRef Hildyard C, Sheikh S, Eyre T, Collins G (2013) Extranodal NK/T cell lymphoma, nasal type, presenting with meningeal infiltration in a Caucasian female. Br J Haematol 163:550CrossRef
8.
go back to reference Cai B, Hu J, Tang Q et al (2014) Primary meningeal NK/T cell lymphoma masquerading as tuberculous meningitis. Neurol Sci 35:1467–1469CrossRef Cai B, Hu J, Tang Q et al (2014) Primary meningeal NK/T cell lymphoma masquerading as tuberculous meningitis. Neurol Sci 35:1467–1469CrossRef
9.
go back to reference Shimatani Y, Nakano Y, Tsuyama N et al (2016) Extranodal NK/T-cell lymphoma, nasal type, manifesting as rapidly progressive dementia without any mass or enhancing brain lesion. Neuropathology 36:456–463CrossRef Shimatani Y, Nakano Y, Tsuyama N et al (2016) Extranodal NK/T-cell lymphoma, nasal type, manifesting as rapidly progressive dementia without any mass or enhancing brain lesion. Neuropathology 36:456–463CrossRef
10.
go back to reference Zuhaimy H, Aziz HA, Vasudevan S, Hui HS (2017) Extranodal natural killer/T-cell lymphoma presenting as orbital cellulitis. GMS Ophthalmol Cases 7:c4 Zuhaimy H, Aziz HA, Vasudevan S, Hui HS (2017) Extranodal natural killer/T-cell lymphoma presenting as orbital cellulitis. GMS Ophthalmol Cases 7:c4
Metadata
Title
Nasal-Type Extranodal Natural Killer/T Cell Lymphoma with Meningeal Involvement: A Case Report and Literature Review
Authors
Chunli Yang
Hongyu Zhuo
Liqun Zou
Publication date
01-04-2020
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2020
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-019-01234-2

Other articles of this Issue 2/2020

Indian Journal of Hematology and Blood Transfusion 2/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine